Stock Financial Ratios

ONS / Oncobiologics, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)16.87
Enterprise Value ($M)34.73
Book Value ($M)-5.20
Book Value / Share-0.30
Price / Book-1.16
NCAV ($M)3.27
NCAV / Share-0.14
Price / NCAV-1.49
Income Statement (mra) ($M)
Net Income-53.33
Balance Sheet (mrq) ($M)
Cash & Equivalents0.14
Cash / Share0.01
Quick Ratio0.28
Current Ratio0.28
Management Effectiveness (mra)
Return on Invested Capital (ROIC)23.00
Return on Assets (ROA)-2.25
Return on Equity (ROE)10.26
Identifiers and Descriptors
Central Index Key (CIK)1649989
Industry Groups
Share Statistics
Common Shares Outstanding (M)24.68
Scoring Models
Piotroski F Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Work In Progress Per Share0.00
Treasury Stock Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Assets Other Non Current Per Share0.05
Liabilities And Stock Equity Per Share1.00
Retained Earnings Per Share-10.45
Additional Paid In Capital Per Share8.75
Property Plant And Equipment Per Share0.88
Property Plant And Equipment Gross Per Share1.34
Accumulated Depreciation And Depletion Per Share0.46
Intangibles Per Share0.00
Cash And Equivalents Per Share0.01
Goodwill Per Share0.00
Assets Per Share1.00
Assets Current Per Share0.07
Minority Interest Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Liabilities Current Per Share2.28
Liabilities Other Non Current Per Share0.05
Accounts Receivable Per Share0.00
Inventory Raw Materials Per Share0.00
Property Plant And Equipment Net Per Share0.88
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Long Term Debt Per Share0.01
Assets Non Current Per Share0.00
Liabilities Per Share2.69
Inventory Per Share0.00
Cash Per Share0.01
Debt Per Share0.01
Equity Per Share-1.68

Related News Stories

How Roche Is Shoring Up Against The Biosimilar Wave

2017-10-02 seekingalpha
In oncology, no company stands to face more competition from the incoming wave of biosimilars that Roche. (105-2)

CUSIP: 68235M105